21339-55-9 | (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$20.00	$14.00
250mg	95%	in stock	$42.00	$29.00
1g	≥98%	in stock	$57.00	$40.00
5g	96%	in stock	$143.00	$100.00
25g	96%	in stock	$654.00	$458.00

Description

• Catalog Number: AB42964
• Chemical Name: (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid
• CAS Number: 21339-55-9
• Molecular Formula: C12H14N2O2
• Molecular Weight: 218.2518
• MDL Number: MFCD00467133
• SMILES: OC(=O)[C@H](Cc1cn(c2c1cccc2)C)N

Computed Properties

• Complexity: 270
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 16
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: -1.3

Literature

• Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.

  Arthritis and rheumatism 20120701

• Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.

  PLoS neglected tropical diseases 20120701

• Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats.

  Cell biochemistry and function 20120601

• Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.

  Kidney international 20120501

• Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.

  Cancer science 20120501

• L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice.

  Journal of immunology (Baltimore, Md. : 1950) 20120415

• Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.

  Bioorganic & medicinal chemistry 20120201

• Novel Cβ-Cγ bond cleavages of tryptophan-containing peptide radical cations.

  Journal of the American Society for Mass Spectrometry 20120201

• Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.

  The Journal of infectious diseases 20120101

• The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression.

  Journal of Alzheimer's disease : JAD 20120101

• IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

  Journal of immunology (Baltimore, Md. : 1950) 20120101

• The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection.

  Journal of biomedical science 20120101

• Modulation of tumor tolerance in primary central nervous system malignancies.

  Clinical & developmental immunology 20120101

• Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

  PloS one 20120101

• Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.

  Clinical & developmental immunology 20120101

• Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.

  Frontiers in immunology 20120101

• The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.

  Immunological investigations 20120101

• On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation.

  Frontiers in immunology 20120101

• The antioxidant role of xanthurenic acid in the Aedes aegypti midgut during digestion of a blood meal.

  PloS one 20120101

• Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.

  PloS one 20120101

• The mechanism of formation of N-formylkynurenine by heme dioxygenases.

  Journal of the American Chemical Society 20111012

• SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.

  The Journal of biological chemistry 20110909

• Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

  Nature medicine 20110901

• The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

  Clinical and experimental immunology 20110801

• Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

  European journal of medicinal chemistry 20110701

• Contribution of dehydroepiandrosterone sulfate and progesterone to in vitro regulation of tolerogenic activity of IFN-α-induced dendritic cells.

  Bulletin of experimental biology and medicine 20110601

• Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20110501

• Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection.

  Parasite immunology 20110401

• Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

  Cancer research 20110315

• Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.

  Medical oncology (Northwood, London, England) 20110301

• Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

  Bioorganic & medicinal chemistry 20110215

• Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

  PloS one 20110101

• Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

  PloS one 20110101

• The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

  PloS one 20110101

• An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.

  PloS one 20110101

• Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.

  Journal of neuroinflammation 20110101

• Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.

  PloS one 20110101

• Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

  Clinical & developmental immunology 20110101

• Tryptophan transport in human fibroblast cells-a functional characterization.

  International journal of tryptophan research : IJTR 20110101

• Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.

  International journal of tryptophan research : IJTR 20110101

• Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.

  Clinical & developmental immunology 20110101

• Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.

  PloS one 20110101

• Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression.

  Transplantation 20101227

• Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.

  Haematologica 20101201

• Pancreatic islet transplants and IDO: when starving the enemy does you good.

  Diabetes 20100901

• A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

  Experimental biology and medicine (Maywood, N.J.) 20100701

• Rational design of indoleamine 2,3-dioxygenase inhibitors.

  Journal of medicinal chemistry 20100211

• Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

  World journal of gastroenterology 20100207

• DC expressing transgene Foxp3 are regulatory APC.

  European journal of immunology 20100201

• The role of indoleamine 2,3-dioxygenase in retinal pigment epithelial cell-mediated immune modulation.

  Ocular immunology and inflammation 20100101

• Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

  Immunology and cell biology 20100101

• Therapeutic cancer vaccines in combination with conventional therapy.

  Journal of biomedicine & biotechnology 20100101

• Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.

  Immunobiology 20100101

• Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.

  PloS one 20100101

• Indoleamine 2,3-dioxygenase: is it an immune suppressor?

  Cancer journal (Sudbury, Mass.) 20100101

• Trends in cancer immunotherapy.

  Clinical Medicine Insights. Oncology 20100101

• IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease.

  International journal of tryptophan research : IJTR 20100101

• Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

  International journal of tryptophan research : IJTR 20100101

• Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.

  Gynecologic oncology 20091101

• IDO and outcomes in ovarian cancer.

  Gynecologic oncology 20091101

• Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.

  Journal of the American Chemical Society 20090916

• Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

  Cancer research 20090701

• IDO inhibits T-cell function through suppressing Vav1 expression and activation.

  Cancer biology & therapy 20090701

• The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.

  Journal of immunology (Baltimore, Md. : 1950) 20090615

• CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.

  European journal of immunology 20090601

• Origins and functional basis of regulatory CD11c+CD8+ T cells.

  European journal of immunology 20090601

• Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

  Experimental & molecular medicine 20090531

• Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

  Molecular psychiatry 20090501

• Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

  Human immunology 20090501

• Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis.

  Clinical and experimental immunology 20090501

• Prevention of spontaneous tumor development in a ret transgenic mouse model by ret peptide vaccination with indoleamine 2,3-dioxygenase inhibitor 1-methyl tryptophan.

  Cancer research 20090501

• Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.

  Journal of the American College of Surgeons 20090501

• Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

  Journal of immunology (Baltimore, Md. : 1950) 20090401

• Tryptophan catabolites regulate mucosal sensitization to ovalbumin in respiratory airways.

  Allergy 20090301

• IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

  Cancer immunology, immunotherapy : CII 20090101

• Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.

  BMC cancer 20090101

• The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.

  Journal of translational medicine 20090101

• The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

  PloS one 20090101

• Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

  BMC cancer 20090101

• Kynurenine pathway metabolites in humans: disease and healthy States.

  International journal of tryptophan research : IJTR 20090101

• The physiological action of picolinic Acid in the human brain.

  International journal of tryptophan research : IJTR 20090101

• Cell cycle arrest by kynurenine in lens epithelial cells.

  Investigative ophthalmology & visual science 20081201

• Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.

  Molecular cancer therapeutics 20081201

• Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

  Langenbeck's archives of surgery 20081101

• The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.

  Journal of immunology (Baltimore, Md. : 1950) 20081015

• Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.

  The Biochemical journal 20080915

• Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.

  Bioorganic & medicinal chemistry 20080915

• Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

  Journal of medicinal chemistry 20080828

• The preference of tryptophan for membrane interfaces: insights from N-methylation of tryptophans in gramicidin channels.

  The Journal of biological chemistry 20080808

• [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].

  Klinische Monatsblatter fur Augenheilkunde 20080801

• Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

  Journal of cancer research and clinical oncology 20080501

• Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.

  Immunology letters 20080415

• Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.

  FEMS immunology and medical microbiology 20080301

• Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

  Blood 20080215

• Increased striatal serotonin synthesis following cortical resection in children with intractable epilepsy.

  Epilepsy research 20080201

• The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma.

  Immunology letters 20080129

• Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.

  Cancer research 20080101

• Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus.

  PloS one 20080101

• Low dose Zebularine treatment enhances immunogenicity of tumor cells.

  Cancer letters 20071108

• Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.

  Experimental eye research 20071101

• Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.

  Clinical and vaccine immunology : CVI 20071101

• Effect of Kidney-replenishing herb on the indoleamine 2,3-dioxygenase of human syncytiotrophoblasts cultured in vitro and the balance of helper T-cell cytokines.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20071101

• Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats.

  Transplantation 20071027

• Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege.

  Journal of immunology (Baltimore, Md. : 1950) 20071015

• Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

  Immunology letters 20070815

• Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.

  Clinical and experimental immunology 20070801

• Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

  Cancer research 20070801

• Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.

  Journal of immunology (Baltimore, Md. : 1950) 20070715

• Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.

  Diabetes 20070601

• Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

  Zhongguo shi yan xue ye xue za zhi 20070601

• HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

  Blood 20070415

• Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.

  Current drug metabolism 20070401

• Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

  Cancer research 20070115

• Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

  Blood 20070101

• Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.

  Arthritis research & therapy 20070101

• Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.

  Immunology letters 20061115

• Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

  Journal of natural products 20061001

• 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.

  Journal of immunology (Baltimore, Md. : 1950) 20060801

• Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.

  Journal of immunology (Baltimore, Md. : 1950) 20060701

• 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.

  Cytokine 20060601

• Perinatal immunotoxicity: why adult exposure assessment fails to predict risk.

  Environmental health perspectives 20060401

• Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage.

  Experimental eye research 20060301

• Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.

  Biotechnology journal 20060301

• Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.

  The Journal of infectious diseases 20060115

• Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

  European journal of immunology 20060101

• Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

  Immunology 20051101

• Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.

  Biology of reproduction 20050901

• Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050801

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.

  Cell research 20050301

• Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.

  Clinical and experimental immunology 20041101

• Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.

  Steroids 20040901

• Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.

  Journal of reproductive immunology 20040401

• Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells.

  Biochimica et biophysica acta 20040210

• Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.

  Human immunology 20040201

• Comparative effects of L-tryptophan and 1-methyl-tryptophan on immunoregulation induced by sperm, human pre-implantation embryo and trophoblast supernatants.

  American journal of reproductive immunology (New York, N.Y. : 1989) 20031001

• Interferon-gamma independent oxidation of melatonin by macrophages.

  Journal of pineal research 20030101

• Tryptophan pyrrole ring cleavage enzymes in placenta.

  Advances in experimental medicine and biology 20030101

• Instruction of translating ribosome by nascent peptide.

  Science (New York, N.Y.) 20020913

• Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

  Science (New York, N.Y.) 20020913

• FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses.

  Journal of immunology (Baltimore, Md. : 1950) 20020815

• Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.

  Journal of neuroimmunology 20020801

• Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.

  The Journal of physiology 20010815

• Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles.

  The Journal of physiology 20010301

• The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

  The Journal of physiology 20010301

• Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.

  Transplantation proceedings 20010101